Projekt

A phase III, open-label, multicenter, randomized study to investigate the efficacy and safety of MPDL3280A (ANTI−PD-L1 ANTIBODY) compared with chemotherapy in patients with locally advanced or metastatic urothelial bladder cancer after failure with platinum-containing chem-otherapy. GO29294

Automatisch geschlossen · 2015 bis 2016

Gillessen Sommer Silke, Templeton Arnoud, Rothermundt Christian, Omlin Aurelius, Desax Marie-Claire